Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma.
Fenk
R
R
Hoyer
B
B
Steidl
U
U
Kondakci
M
M
Graef
T
T
Heuk
R
R
Ruf
L
L
Strupp
C
C
Neumann
F
F
Rohr
U-P
UP
Hildebrandt
B
B
Haas
R
R
Kobbe
G
G
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D012008:Recurrence; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D013792:Thalidomide